Tango Therapeutics Balance Sheet
NASDAQ: TNGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Tango Therapeutics financial position
At the end of fiscal 2025, Tango Therapeutics reported total assets of $398.7 million, up 26.0% from a year earlier against total liabilities of $52.5 million. Shareholders' equity stood at $346.2 million, or 86.8% of assets. The company held $112.3 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 16.32, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Tango Therapeutics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 112.28M | 69.53M | 66.39M | 59.97M | 142.75M | 28.38M |
| Short-Term Investments | 230.86M | 188.39M | 270.50M | 306.17M | 342.51M | 161.94M |
| Receivables | — | — | — | 2.00M | 2.00M | 2.00M |
| Total Current Assets | 353.76M | 266.34M | 346.54M | 375.27M | 492.34M | 193.63M |
| Property, Plant & Equipment | 6.87M | 8.10M | 9.91M | 10.88M | 4.83M | 3.82M |
| Total Assets | 398.69M | 316.49M | 402.57M | 436.47M | 500.15M | 207.25M |
| Accounts Payable | 1.18M | 1.60M | 2.79M | 4.45M | 3.23M | 1.84M |
| Total Current Liabilities | 21.68M | 38.17M | 45.94M | 55.55M | 40.69M | 40.92M |
| Total Liabilities | 52.51M | 116.97M | 149.46M | 186.99M | 155.41M | 168.65M |
| Shareholders' Equity | 346.18M | 199.52M | 253.11M | 249.48M | 344.75M | 38.60M |
| Retained Earnings | -603.15M | -501.56M | -371.26M | -269.51M | -161.34M | -103.10M |
| Net Cash (Debt) | 343.14M | 257.92M | 336.88M | 366.13M | 485.25M | 190.32M |
| Shares Outstanding | 135.94M | 107.73M | 102.20M | 88.18M | 87.60M | 40.37M |
This table shows 6 annual periods of Tango Therapeutics's balance sheet, from FY 2025 back to FY 2020, across 13 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow TNGX's reporting calendar. What is a balance sheet?